The diagnosis of advanced fibrosis in patients with liver disease is important in guiding both the initiation of screening for complications of cirrhosis and treatment decisions. Liver biopsy is still the current gold standard test for identifying advanced fibrosis; however, less-invasive tests have been described, including a serum test of aspartate aminotransferase to platelet ratio index (APRI) and Fibroscan, …